Target intelligence / Profile preview

Novel transcript, antisense to MYT1L

Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

ENSG00000284600, termed "novel transcript, antisense to MYT1L," is a long non-coding RNA located on chromosome 2, transcribed in the direction opposite to the MYT1L gene[1][4]. As an antisense lncRNA, it does not code for a protein but overlaps with the MYT1L locus, allowing it to potentially influence the expression of the MYT1L gene through various mechanisms common to antisense transcripts. These mechanisms may include transcriptional interference, RNA masking, double-stranded RNA-mediated effects (like RNA interference), and influencing chromatin state, all of which can affect the production, processing, and stability of the corresponding sense transcript[2][5]. While antisense lncRNAs as a class are functionally diverse, the precise biological role, disease association, or therapeutic relevance of this particular transcript remains uncharacterized.

Other names
Novel transcript, antisense to MYT1LENSG00000284600
02

Biological functions

Regulation of gene expression (via antisense transcription)Chromatin modification and remodelingModulation of sense (MYT1L) transcript stability, processing, and production
03

Disease associations

Other (potential role in neurological disorders could be inferred due to position relative to MYT1L, but not established)

Beyond the preview

Go deeper on Novel transcript, antisense to MYT1L.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to MYT1L.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call